Nevertheless, sustained chronic stimulation of cancer-related antigens within the TME or augmented infiltration of anti-inflammatory M2-like macrophages and cancer-associated fibroblasts often impedes the ability of CD8+ T cells to induce tumor regression in advanced cancer patients [8]. Here, CD8A is linked to cancer.